Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.
暂无分享,去创建一个
S. Hammer | E. Shane | D. McMahon | M. Yin | A. Shu | J. Laurence | R. Staron | Chiyuan A. Zhang | J. Dobkin | I. Colon | D. Ferris | Aimee D. Shu
[1] M. King,et al. Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen , 2009, Journal of acquired immune deficiency syndromes.
[2] C. Katlama,et al. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. , 2009, AIDS.
[3] S. Silverman,et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. , 2008, Bone.
[4] T. Brown,et al. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. , 2008, The Journal of clinical endocrinology and metabolism.
[5] S. Wallenstein,et al. Risk factors for decreased bone density and effects of HIV on bone in the elderly , 2008, Osteoporosis International.
[6] I. Reid,et al. CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[7] V. Luther,et al. HIV infection in older adults. , 2007, Clinics in geriatric medicine.
[8] A. Cheng,et al. The Safety and Efficacy of Tenofovir DF in Combination with Lamivudine and Efavirenz Through 6 Years in Antiretroviral-Naïve HIV-1—Infected Patients , 2007, HIV clinical trials.
[9] Y. Lo,et al. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection , 2007, AIDS.
[10] T. Brown,et al. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review , 2006, AIDS.
[11] S. Grinspoon,et al. Longitudinal analysis of bone density in human immunodeficiency virus-infected women. , 2006, The Journal of clinical endocrinology and metabolism.
[12] I. Reid,et al. Bone mineral density is not reduced in HIV‐infected Caucasian men treated with highly active antiretroviral therapy , 2006, Clinical endocrinology.
[13] J. Arnsten,et al. HIV infection and bone mineral density in middle-aged women. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] E. Shane,et al. Bone mass and mineral metabolism in HIV+ postmenopausal women , 2005, Osteoporosis International.
[15] Michael W.-H. Wang,et al. The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. , 2004, The Journal of clinical investigation.
[16] Jeannie S. Huang,et al. Reduced bone density in HIV-infected women , 2004, AIDS.
[17] J. Laurence,et al. HIV Envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor κB Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-γ/RANKL Cross-talk* , 2003, Journal of Biological Chemistry.
[18] L. Bergoglio,et al. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy , 2003, AIDS.
[19] R. Bretzel,et al. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. , 2003, The Journal of infection.
[20] K. Yarasheski,et al. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] L. Tatò,et al. Altered bone metabolism in children infected with human immunodeficiency virus , 2003, Acta paediatrica.
[22] J. Kanis,et al. Diagnosis of osteoporosis and assessment of fracture risk , 2002, The Lancet.
[23] J. Lenhard,et al. Select HIV Protease Inhibitors Alter Bone and Fat Metabolismex Vivo * , 2002, The Journal of Biological Chemistry.
[24] A. Klibanski,et al. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. , 2001, The Journal of clinical endocrinology and metabolism.
[25] X. Nogués,et al. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? , 2001, AIDS.
[26] J. Eisman,et al. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy , 2001, AIDS.
[27] K. Yarasheski,et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy , 2000, AIDS.
[28] Y. Taketani,et al. A possible role of estrone produced in adipose tissues in modulating postmenopausal bone density. , 1995, Maturitas.
[29] Robert Epstein,et al. Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] Ann A. Hertzler,et al. A dietary calcium rapid assessment method (RAM) , 1994 .
[31] J. Halter,et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] A. Justice,et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] J. Bollerslev,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Decreased Bone Formative and Enhanced Resorptive Markers in Human Immunodeficiency Virus Infection: Indication of Normalization of the Bone-Remode , 2022 .